Podcast
Questions and Answers
Which drug is indicated for the treatment of symptoms associated with chronic asthma or other chronic lung diseases?
Which drug is indicated for the treatment of symptoms associated with chronic asthma or other chronic lung diseases?
- Ipratropium
- Tiotropium
- Aclidinium
- Theophylline (correct)
What is the mechanism of action of the drug Ipratropium?
What is the mechanism of action of the drug Ipratropium?
- Inducing smooth muscle relaxation
- Muscarinic cholinergic receptor antagonist (correct)
- Suppressing response of the airways to stimuli
- Inhibition of phosphodiesterase enzymes
What is the most significant adverse effect associated with Ipratropium?
What is the most significant adverse effect associated with Ipratropium?
- Closed angle glaucoma
- Dry mouth
- Paradoxical bronchospasm (correct)
- Dizziness
Which anticholinergic agent has a duration of 2-4 hours when administered through metered-dose inhaler (MDI)?
Which anticholinergic agent has a duration of 2-4 hours when administered through metered-dose inhaler (MDI)?
What is the primary mechanism of action of Tiotropium?
What is the primary mechanism of action of Tiotropium?
What is an important warning/caution associated with Tiotropium use?
What is an important warning/caution associated with Tiotropium use?
Which medication is indicated for moderate to severe asthma in patients older than 6 years old?
Which medication is indicated for moderate to severe asthma in patients older than 6 years old?
What is the primary mechanism of action of Theophylline?
What is the primary mechanism of action of Theophylline?
What is an important warning/caution associated with Ipratropium use?
What is an important warning/caution associated with Ipratropium use?
What can be used as monotherapy or as a combination with other bronchodilators, especially beta adrenergic?
What can be used as monotherapy or as a combination with other bronchodilators, especially beta adrenergic?
Methylxanthine drugs are no longer recommended for the treatment of COPD according to the new GOLD criteria.
Methylxanthine drugs are no longer recommended for the treatment of COPD according to the new GOLD criteria.
Theophylline has a relatively narrow therapeutic range with a low incidence of adverse effects.
Theophylline has a relatively narrow therapeutic range with a low incidence of adverse effects.
Ipratropium is well absorbed systemically after inhalation.
Ipratropium is well absorbed systemically after inhalation.
Tiotropium is indicated for the treatment of asthma in patients younger than 6 years old.
Tiotropium is indicated for the treatment of asthma in patients younger than 6 years old.
Ipratropium/albuterol combination inhaler is indicated as a rescue inhaler for acute bronchospasm.
Ipratropium/albuterol combination inhaler is indicated as a rescue inhaler for acute bronchospasm.
What factor contributes to the removal of methylxanthine drugs from the 2018 GOLD criteria for COPD treatment?
What factor contributes to the removal of methylxanthine drugs from the 2018 GOLD criteria for COPD treatment?
Which drug has a relatively weak bronchodilator effect and a narrow therapeutic range?
Which drug has a relatively weak bronchodilator effect and a narrow therapeutic range?
What is the primary mechanism of action of Ipratropium?
What is the primary mechanism of action of Ipratropium?
Which drug has a duration of 2-4 hours when administered through a metered-dose inhaler (MDI)?
Which drug has a duration of 2-4 hours when administered through a metered-dose inhaler (MDI)?
Which anticholinergic agent is indicated for moderate to severe asthma in patients older than 6 years old?
Which anticholinergic agent is indicated for moderate to severe asthma in patients older than 6 years old?
Flashcards are hidden until you start studying
